-transparent.png){kind=logo}
Bronchial asthma is associated with increased levels of exhaled nitric oxide which are suppressible by glucocorticosteroid inhalation. Children with bronchial asthma were studied to elucidate the relation between endogenous NO release and recent symptoms of bronchial obstruction. Twenty-five children with atopic asthma and 11 healthy control subjects were enrolled and exhaled NO was studied using chemiluminescence analysis. The subjects breathed purified air (<0.5 parts per billion (ppb) NO) exclusively through their mouths. Orally expired NO was measured during continuous nasal aspiration (1.3 L x min(-1)) to remove nasally produced NO. Nasal NO concentration was determined within the aspirated gas. Orally expired NO concentration was 2.5+/-0.3 ppb (mean +/-SEM) in healthy control subjects, 3.19+/-0.88 ppb (NS) in symptom-free children, and 8.28+/-0.81 ppb (p< or =0.01) in children with bronchial asthma who had had recent symptoms of bronchial obstruction. Similarly, in the subgroup of children treated regularly with inhaled glucocorticosteroids those with recent symptoms had significantly higher orally exhaled NO concentrations than healthy control subjects (9.5+/-1.5 ppb, p<0.05). The nasal NO concentration was 152.8+/-12.7 ppb in healthy control subjects and not significantly different in asthmatic children. In this group of asthmatic children, recent symptoms of bronchial obstruction were linked to significantly higher concentrations of NO in orally exhaled gas and to increased oral NO excretion rates. If substantiated by further studies, measurement of orally exhaled NO during nasal aspiration may become useful to monitor disease control in asthmatic children.
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
October 2004,
The Journal of asthma : official journal of the Association for the Care of Asthma,
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
August 1996,
European journal of pediatrics,
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
April 1999,
Arerugi = [Allergy],
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
March 2010,
The Journal of pediatrics,
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
May 2011,
Respiratory research,
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
February 2008,
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
February 2004,
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
September 2008,
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
October 1998,
American journal of respiratory and critical care medicine,
A Artlich, and
T Busch, and
K Lewandowski, and
S Jonas, and
L Gortner, and
K J Falke
December 2009,
BMJ (Clinical research ed.),
